175
Participants
Start Date
August 31, 2016
Primary Completion Date
July 18, 2017
Study Completion Date
July 18, 2017
FLU-v
Subcutaneous injection in the upper arm with 500 ug of FLU-v as 0.5ml suspension in 0.01M HCl and 0.01M NaOH
adjuvanted FLU-v
Subcutaneous injection in the upper arm with 500ug of FLU-v emulsified in 0.25ml of Montanide ISA-51 adjuvant (Seppic, France) and 0.25ml of water for injection
Saline
Subcutaneous injection in the upper arm with 0.5ml of saline
Adjuvanted placebo
Subcutaneous injection in the upper arm with an emulsion made with 0.25ml of Montanide ISA-51 adjuvant (Seppic, France) and 0.25ml of water for injection
Isala, Zwolle
Seventh Framework Programme
OTHER
University of Groningen
OTHER
University Medical Center Groningen
OTHER
Robert Koch Institut
OTHER_GOV
Norwegian Institute of Public Health
OTHER_GOV
PepTcell Limited
INDUSTRY